Involvement of mast cells, sensory afferents and sympathetic mechanisms in paw oedema induced by adenosine A1 and A(2B/3) receptor agonists

European Journal of Pharmacology

Volumn 395, Issue 1, 2000, Pages 47-50

  Sawynok, Jana ^a   Reid, Allison ^a   Liu, Xue Jun ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adenosine A(2B) receptor; Adenosine A1 receptor; Mast cell; Oedema

Indexed keywords

6 N BENZYL 5' N ETHYLCARBOXAMIDOADENOSINE; 6 N CYCLOPENTYLADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2B RECEPTOR; CAPSAICIN; COMPOUND 48-80; OXIDOPAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MALE; MAST CELL; NONHUMAN; PATHOGENESIS; PAW EDEMA; PRIORITY JOURNAL; RAT; SENSORY NERVE; SYMPATHETIC INNERVATION;

ADENOSINE; ANIMALS; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; HINDLIMB; MALE; MAST CELLS; NEURONS, AFFERENT; OXIDOPAMINE; P-METHOXY-N-METHYLPHENETHYLAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2B; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOLYTICS;

EID: 0034696926     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00125-4     Document Type: Article

References (22)

1. Aley K.O., Green P.G., Levine J.D. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal. J. Neurosci. 15:1995;8031-8038.
2. Amman R., Schuligoi R., Lanz I., Donnerer J. Histamine-induced edema in the rat paw-effect of capsaicin denervation and a CGRP receptor antagonist. Eur. J. Pharmacol. 279:1995;227-231.
3. Arvier P.T., Chahl L.A., Ladd R.J. Modification by capsaicin and compound 48/80 of dye leakage induced by irritants in the rat. Br. J. Pharmacol. 59:1977;61-68.
4. Coderre T.J., Basbaum A.I., Levine J.D. Neural control of vascular permeability: interactions between primary afferents, mast cells, and sympathetic efferents. J. Neurophysiol. 62:1989;48-58.
5. Damas J., Liégois J.F. The inflammatory reaction induced by formalin in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 359:1999;220-227.
6. Donnerer J., Amman R., Lembeck F. Neurogenic and non-neurogenic inflammation in the rat paw following chemical sympathectomy. Neuroscience. 45:1991;761-765.
7. Dowd E., McQueen D.S., Chessell I.P., Humphrey P.P.A. Adenosine A1 receptor-mediated excitation of nociceptive afferents innervating the normal and arthritic rat knee joint. Br. J. Pharmacol. 125:1998;1267-1271.
8. Feoktistov I., Biaggioni I. Adenosine A2B receptors. Pharmacol. Rev. 49:1997;381-402.
9. Hannon J.P., Pfannkuche H.J., Fozard J.R. A role for mast cells in adenosine A3 receptor-mediated hypotension in the rat. Br. J. Pharmacol. 115:1995;945-952.
10. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience. 24:1988;739-768.
11. Hong J.L., Ho C.Y., Kwong K., Lee L.Y. Activation of pulmonary C fibres by adenosine in anaesthetized rats: role of adenosine A1 receptors. J. Physiol. 508:1998;109-118.
12. Linden J. Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol. Sci. 15:1994;298-306.
13. Liu X.J., Sawynok J. Peripheral antihyperalgesic effect of adenosine A1 receptor agonists in a rat neuropathic pain model. Soc. Neurosci. Abstr. 24:1998;1630.
14. Nakamura M., Ferreira S.H. A peripheral sympathetic component in inflammatory hyperalgesia. Eur. J. Pharmacol. 135:1987;145-153.
15. Perrot S., Attal N., Ardid D., Gilbaud G. Are mechanical and cold allodynia in mononeuropathic and arthritic rats relieved by systemic treatment with calcitonin or guanethidine. Pain. 52:1994;41-47.
16. Ramkumar V., Stiles G.L., Beaven M.A., Ali H. The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem. 268:1993;16887-16890.
17. Salmon J.E., Cronstein B.N. Fcγ receptor-mediated functions in neutrophils are modulated by adenosine receptor occupancy. A1 receptors are stimulatory and A2 receptors are inhibitory. J. Immunol. 145:1990;2235-2240.
18. Sawynok J., Reid A., Liu X.J. Acute paw oedema induced by local application of adenosine A1, A2 and A3 receptor agonists. Eur. J. Pharmacol. 386:1999;253-261.
19. Sawynok J., Zarrindast M.R., Reid A.R., Doak G.J. Adenosine A3 receptor activation produces nociceptive behaviour and edema by release of histamine and 5-hydroxytryptamine. Eur. J. Pharmacol. 333:1997;1-7.
20. Sufka K.J., Schomburg F.M., Giordano J. Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmacol. Biochem. Behav. 41:1991;53-56.
21. Woolf C.J., Ma Q.-P., Allchorne A., Poole S. Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation. J. Neurosci. 16:1996;2716-2723.
22. Zhou L., Zhang Q., Stein C., Schafer M. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. J. Pharmacol. Exp. Ther. 286:1998;1000-1006.